Hot Pursuit     05-Apr-23
Biocon Ltd spurts 2.7%, up for third straight session
Biocon Ltd is quoting at Rs 215, up 2.7% on the day as on 12:49 IST on the NSE. The stock is down 38.62% in last one year as compared to a 1.55% slide in NIFTY and a 11.83% slide in the Nifty Metal index.

Biocon Ltd is up for a third straight session today. The stock is quoting at Rs 215, up 2.7% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.77% on the day, quoting at 17531.7. The Sensex is at 59617.92, up 0.87%. Biocon Ltd has slipped around 5.04% in last one month.

Meanwhile, Nifty Metal index of which Biocon Ltd is a constituent, has slipped around 2.74% in last one month and is currently quoting at 12067.95, up 0.52% on the day. The volume in the stock stood at 52.9 lakh shares today, compared to the daily average of 76.76 lakh shares in last one month.

The benchmark April futures contract for the stock is quoting at Rs 215.8, up 2.49% on the day. Biocon Ltd is down 38.62% in last one year as compared to a 1.55% slide in NIFTY and a 11.83% slide in the Nifty Metal index.

The PE of the stock is 143.05 based on TTM earnings ending December 22.

Previous News
  Biocon Ltd up for five straight sessions
 ( Hot Pursuit - 19-Feb-24   13:00 )
  Biocon Ltd spurts 1.22%, gains for third straight session
 ( Hot Pursuit - 07-Jun-24   13:05 )
  Biocon’s Andhra Pradesh facility gets 3 USFDA observations
 ( Hot Pursuit - 15-Jun-24   16:32 )
  Biocon gains after receiving MHRA UK approval for Liraglutide injection
 ( Hot Pursuit - 01-Apr-24   10:34 )
  Market at day’s high; VIX climbs 3.96%; realty shares advance
 ( Market Commentary - Mid-Session 18-Apr-24   12:37 )
  Board of Biocon recommends final dividend
 ( Corporate News - 16-May-24   17:54 )
  Biocon initiates clinical study of Itolizumab for Ulcerative Colitis in India
 ( Corporate News - 14-Dec-22   19:23 )
  Biocon Ltd soars 0.15%, up for fifth straight session
 ( Hot Pursuit - 20-Jul-23   13:00 )
  Biocon receives credit ratings from India Ratings and Research
 ( Corporate News - 08-Feb-23   19:19 )
  Biocon gets US FDA approval for market generic version of anti-cancer drug
 ( Hot Pursuit - 07-Feb-24   09:35 )
  Biocon inks pact with Juno Pharma for commercialization of Liraglutide
 ( Hot Pursuit - 09-Oct-23   10:11 )
Other Stories
  Tata Motors JLR wholesale rises 5% YoY in Q1
  06-Jul-24   13:01
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
Back Top